title: Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages.
abstract: The potential for tissue factor (TF) to enhance inflammation by factor VIIa-dependent induction of proinflammatory changes in macrophages was explored. Purified recombinant human factor VIIa enhanced reactive oxygen species production by human monocyte-derived macrophages expressing TF in vitro. This effect was dose- and time-dependent, ligand- and receptor-specific, and independent of other coagulation proteins. This receptor/ligand binding induced phospholipase C-dependent intracellular calcium fluxes. Transfection studies using a human monocyte-derived cell line (U937) demonstrated that an intact intracytoplasmic domain of TF is required for factor VIIa-induced intracellular calcium fluxes. The capacity of TF to enhance proinflammatory functions of rabbit peritoneal-elicited macrophages (production of reactive oxygen species and expression of major histocompatibility complex class II and cell adhesion molecules) was demonstrated in vivo by treatment with an anti-TF antibody. These data demonstrate that, in addition to its role in activation of coagulation, TF can directly augment macrophage activation. These effects are initiated by binding factor VIIa and are independent of other coagulation proteins. These studies provide the first demonstration of a direct proinflammatory role for TF acting as a cell-signaling receptor.
authors.affiliation: Centre for Inflammatory Diseases, Monash University, Department of Medicine, Monash Medical Centre, Clayton, Victoria, Australia.
authors.forename: M A
authors.initials: MA
authors.lastname: Cunningham
authors.forename: P
authors.initials: P
authors.lastname: Romas
authors.forename: P
authors.initials: P
authors.lastname: Hutchinson
authors.forename: S R
authors.initials: SR
authors.lastname: Holdsworth
authors.forename: P G
authors.initials: PG
authors.lastname: Tipping
mesh_terms: D000906:Antibodies / Q000494:pharmacology; D001692:Biological Transport; D002118:Calcium / Q000378:metabolism; D002454:Cell Differentiation; D003593:Cytoplasm / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D015942:Factor VIIa / Q000378:metabolism*; D006801:Humans; D007249:Inflammation / Q000378:metabolism*; D018836:Inflammation Mediators / Q000378:metabolism*; D008024:Ligands; D008262:Macrophage Activation / Q000187:drug effects; D008264:Macrophages / Q000166:cytology / Q000378:metabolism*; D017737:Macrophages, Peritoneal / Q000187:drug effects / Q000378:metabolism; D009000:Monocytes / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism; D015398:Signal Transduction; D013917:Thrombin / Q000378:metabolism; D013925:Thromboplastin / Q000276:immunology / Q000378:metabolism*; D013997:Time Factors; D020298:U937 Cells; D015854:Up-Regulation
chemical_list: D000906:Antibodies; D018836:Inflammation Mediators; D008024:Ligands; D017382:Reactive Oxygen Species; D013925:Thromboplastin; D015942:Factor VIIa; D013917:Thrombin; D002118:Calcium